Access Vascular was founded in 2015 to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. The company develops intravenous catheters and ports from patented biomaterials which are highly biocompatible and are capable of long-term infection protection. Access Vascular’s first product, HydroPICC, began commercial use in early 2019, future applications include midlines, dialysis catheters, ports, and other devices. For more information, please visit www.accessvascularinc.com.
175 Middlesex Turnpike
Bedford, Massachusetts 01730